ReviewFrontiers in immunology2021

Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies.

Vitaly Chasov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.